October 19, 2026

Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC

Tempus: Study presented at ESMO evaluated more than 60,000 advanced NSCLC cases and found greater than 80% sensitivity across all 12 biomarkers using routine H&E pathology images CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM) today...

recent articles

Do you face variability between digital slide images when performing your image analysis? Join Jeni Caldara, Professional Services Specialist, in the next webinar of Visiopharm’s ‘Mastering your image analysis skills’ series...

PRESS RELEASE: Expert Report calls for pathologists to engage hospital administrators to address key challenges and opportunities to improve cancer diagnostics and patient care London, UK – Apr. 23, 2020 – Leica Biosystems, a...

St. Jacobs, Ontario, Canada – April 22, 2020 – Huron Digital Pathology announced today that it has been granted a US patent for barcoding digital images. The invention forms the basis for Huron’s image search platform. Related to the...

Media Release: Roche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer More than 99 percent of cervical cancers are caused by persistent high-risk HPV...

How to successfully lead your lab through the legislative and regulatory landscape of COVID-19 Dark Daily is offering this FREE webinar as a service to our clinical lab and pathology colleagues Tomorrow, Wed., April 22 at 1 PM EDT Register...

Access to cloud-based platform during COVID-19 pandemic For pathologists and scientists who are working from home, and to enable remote working for those who are not currently able to practice social distancing measures due to a lack of...

OR

platinum partners

gold partners

Silver Partners

Media Partners